ArticleHistopathology2025

ROS1 immunohistochemistry as a potential predictive biomarker for ROS1-targeted therapy in breast cancer: impact of antibody clone selection.

Anna Sokolova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.